Committed to providing exceptional care and continued support to patients, families and caregivers.



Disease Type: Lung
Status: Open

Trial Information

A Dose Frequency Optimization, Phase IIIB/IV Trial of Nivolumab 3 mg/kg Every 2 Weeks vs Nivolumab 6 mg/kg Every 4 Weeks in Subjects with Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer who Received 4 Months of Nivolumab at 3 mg/kg Every 2 Weeks

Click here for more information

This trial is available at:

Methodist Estabrook Cancer Center
8303 Dodge Street, Suite 250, Omaha, NE 68114
Phone: 402-354-8124
Fax: 402-354-8127

Midwest Cancer Center – Legacy
17201 Wright Street, Suite 200, Omaha, NE 68130
Phone: 402-334-4773
Fax: 402-330-7463

Midwest Cancer Center – Papillion
611 Fenwick Drive, Papillion, NE 68046
Phone: 402-593-3141
Fax: 402-593-3145

For more information, please contact: